Transcriptional mechanisms for the Wilms’ tumor gene 1 (WT1) oncoprotein
1 – 28 of 28
- show: 50
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
-
Mark
Depletion of the transcriptional coactivators CREB-binding protein or EP300 downregulates CD20 in diffuse large B-cell lymphoma cells and impairs the cytotoxic effects of anti-CD20 antibodies
(
- Contribution to journal › Article
-
Mark
Lin28b controls a neonatal to adult switch in B cell positive selection
(
- Contribution to journal › Article
-
Mark
Searching for WT1 target genes in leukemic cell lines
(
- Thesis › Doctoral thesis (compilation)
- 2018
-
Mark
Target Genes of WT1 in Leukemic Cells
2018) Scientific Symposium -European Academy for Biomedical Science(
- Contribution to conference › Poster
-
Mark
Identification of multiple risk loci and regulatory mechanisms influencing susceptibility to multiple myeloma
(
- Contribution to journal › Article
-
Mark
Role of ZNF224 in c-Myc repression and imatinib responsiveness in chronic myeloid leukemia
(
- Contribution to journal › Article
-
Mark
The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression
(
- Contribution to journal › Article
- 2017
-
Mark
Distinct global binding patterns of the Wilms' tumor gene 1 (WT1) -KTS and +KTS isoforms in leukemic cells
(
- Contribution to journal › Article
-
Mark
The transcriptional coregulator NAB2 is a target gene for the Wilms' tumor gene 1 protein (WT1) in leukemic cells
(
- Contribution to journal › Article
-
Mark
Direct evidence for a polygenic etiology in familial multiple myeloma
(
- Contribution to journal › Article
-
Mark
The HDAC inhibitor valproate induces a bivalent status of the CD20 promoter in CLL patients suggesting distinct epigenetic regulation of CD20 expression in CLL in vivo
(
- Contribution to journal › Article
- 2016
-
Mark
The hematopoietic tumor suppressor interferon regulatory factor 8 (IRF8) is upregulated by the antimetabolite cytarabine in leukemic cells involving the zinc finger protein ZNF224, acting as a cofactor of the Wilms' tumor gene 1 (WT1) protein.
(
- Contribution to journal › Article
- 2015
-
Mark
The DEK oncoprotein and its emerging roles in gene regulation.
(
- Contribution to journal › Scientific review
-
Mark
WT1-mediated repression of the proapoptotic transcription factor ZNF224 is triggered by the BCR-ABL oncogene.
(
- Contribution to journal › Article
- 2014
-
Mark
The DEK oncoprotein binds to highly and ubiquitously expressed genes with a dual role in their transcriptional regulation.
(
- Contribution to journal › Article
- 2013
-
Mark
Leukemia associated mutant Wilms' tumor gene 1 protein promotes expansion of human hematopoietic progenitor cells.
2013) In Leukemia Research: A Forum for Studies on Leukemia and Normal Hemopoiesis 37(10). p.1341-1349(
- Contribution to journal › Article
-
Mark
Role of WT1-ZNF224 interaction in the expression of the tumor suppressor interferon regulatory factor 8 in leukemia cells
2013) 38th FEBS Congress Molecules of Life(
- Contribution to conference › Abstract
- 2010
-
Mark
Wilms' tumor gene 1 protein represses the expression of the tumor suppressor interferon regulatory factor 8 in human hematopoietic progenitors and in leukemic cells.
(
- Contribution to journal › Article
-
Mark
The leukemia associated ETO nuclear repressor gene is regulated by the GATA-1 transcription factor in erythroid/megakaryocytic cells
(
- Contribution to journal › Article
- 2008
-
Mark
Gene expression analysis of BCR/ABL1-dependent transcriptional response reveals enrichment for genes involved in negative feedback regulation.
(
- Contribution to journal › Article
- 2007
-
Mark
Deregulation of the Wilms' tumour gene 1 protein (WT1) by BCR/ABL1 mediates resistance to imatinib in human leukaemia cells
(
- Contribution to journal › Article
- 2001
-
Mark
Forced expression of the Wilms tumor 1 (WT1) gene inhibits proliferation of human hematopoietic CD34(+) progenitor cells
(
- Contribution to journal › Article
- 2000
-
Mark
p53-mediated differentiation of the erythroleukemia cell line K562
(
- Contribution to journal › Article
- 1999
-
Mark
Involvement of the retinoblastoma protein in monocytic and neutrophilic lineage commitment of human bone marrow progenitor cells
(
- Contribution to journal › Article
- 1998
-
Mark
p53-dependent and -independent differentiation of leukemic U-937 cells : relationship to cell cycle control
(
- Contribution to journal › Article
-
Mark
Constitutive expression of the Wilms' tumor gene (WT1) in the leukemic cell line U937 blocks parts of the differentiation program
(
- Contribution to journal › Article
- 1997
-
Mark
The tumor suppressor gene p53 can mediate transforming growth [corrected] factor beta1-induced differentiation of leukemic cells independently of activation of the retinoblastoma protein
(
- Contribution to journal › Article
- 1996
-
Mark
Cell differentiation in acute myeloid leukemia
(
- Contribution to journal › Scientific review